Drugs & Targets Tecentriq receives FDA approval for alveolar soft part sarcoma December 16, 2022Vol.48 No.45
Drugs & Targets Krazati receives FDA accelerated approval for KRAS G12C-mutated NSCLC December 16, 2022Vol.48 No.45
Guest Editorial PAMN: How cancer centers develop ways to communicate the value of research December 09, 2022Vol.48 No.44By Heidi Findlay
In Brief Prostate Cancer Foundation awards $30M in new funding for innovative research December 09, 2022Vol.48 No.44
In Brief Barbara Burtness named chief translational research officer at Yale December 09, 2022Vol.48 No.44
In Brief Alessandro Fatatis named associate director of basic research at SKCC December 09, 2022Vol.48 No.44
In Brief Robert W. Sobol named associate director of basic research at Brown December 09, 2022Vol.48 No.44
In Brief Sendurai A. Mani named associate director of translational oncology at Brown December 09, 2022Vol.48 No.44
